Your browser doesn't support javascript.
loading
Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial.
Luttikhold, Joanna; van Norren, Klaske; Rijna, Herman; Buijs, Nikki; Ankersmit, Marjolein; Heijboer, Annemieke C; Gootjes, Jeannette; Hartmann, Bolette; Holst, Jens J; van Loon, Luc Jc; van Leeuwen, Paul Am.
Afiliação
  • Luttikhold J; Nutricia Research, Utrecht, Netherlands; Departments of Surgery and j.luttikhold@vumc.nl.
  • van Norren K; Nutrition and Pharmacology Group, Division of Human Nutrition, Wageningen University, Wageningen, Netherlands;
  • Rijna H; Department of Surgery, Spaarne Gasthuis, Haarlem, Netherlands;
  • Buijs N; Departments of Surgery and.
  • Ankersmit M; Departments of Surgery and.
  • Heijboer AC; Clinical Chemistry, VU University Medical Center, Amsterdam, Netherlands;
  • Gootjes J; Atalmedial Diagnostic Center, Hoofddorp, Netherlands;
  • Hartmann B; The Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Copenhagen, Denmark; and.
  • Holst JJ; The Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Copenhagen, Denmark; and.
  • van Loon LJ; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, Netherlands.
  • van Leeuwen PA; Departments of Surgery and.
Am J Clin Nutr ; 103(2): 435-43, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26762368
ABSTRACT

BACKGROUND:

Jejunal feeding is preferred instead of gastric feeding in patients who are intolerant to gastric feeding or at risk of aspiration. However, the impact of gastric feeding compared with that of jejunal feeding on postprandial circulating plasma glucose and amino acid concentrations and the associated endocrine response in vivo in humans remains largely unexplored.

OBJECTIVE:

We compared the impact of administering enteral nutrition as either gastric feeding or jejunal feeding on endocrine responses in vivo in humans.

DESIGN:

In a randomized, crossover study design, 12 healthy young men (mean ± SD age 21 ± 2 y) received continuous enteral nutrition that contained noncoagulating proteins for 12 h via a nasogastric tube or a nasojejunal tube placed 30-40 cm distal to the ligament of Treitz. Blood samples were collected during the 12-h postprandial period to assess the rise in plasma glucose, amino acid, and gastrointestinal hormone concentrations.

RESULTS:

No differences were observed in the postprandial rise in circulating plasma amino acid and glucose concentrations between regimens. Jejunal feeding resulted in higher peak plasma insulin concentrations than did gastric feeding (392 ± 53 compared with 326 ± 54 pmol/L, respectively; P < 0.05). The postprandial rise in plasma cholecystokinin, peptide YY (PYY), glucagon-like peptide 1 (GLP-1), and glucagon-like peptide 2 (GLP-2) concentrations was greater after jejunal feeding than after gastric feeding, with higher peak concentrations and a greater postprandial incremental AUC for GLP-1 and cholecystokinin (all P < 0.05). Plasma ghrelin concentrations did not differ between regimens.

CONCLUSIONS:

Enteral nutrition with gastric or jejunal feeding in healthy young men results in similar postprandial plasma amino acid and glucose concentrations. However, the endocrine response differs substantially, with higher peak plasma cholecystokinin, PYY, GLP-1, and GLP-2 concentrations being attained after jejunal feeding. This effect may result in an improved anabolic response, greater insulin sensitivity, and an improved intestinotropic effect. Nevertheless, it may also lead to delayed gastric emptying. This trial was registered at trialregister.nl as NTR2801.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Colecistocinina / Regulação para Cima / Nutrição Enteral / Peptídeo YY / Peptídeo 1 Semelhante ao Glucagon / Peptídeo 2 Semelhante ao Glucagon / Mucosa Intestinal Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: Am J Clin Nutr Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Colecistocinina / Regulação para Cima / Nutrição Enteral / Peptídeo YY / Peptídeo 1 Semelhante ao Glucagon / Peptídeo 2 Semelhante ao Glucagon / Mucosa Intestinal Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: Am J Clin Nutr Ano de publicação: 2016 Tipo de documento: Article